Related Experiment Video

Updated: May 20, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

[Transmission of Pneumocystis infection in humans]

Magali Chabé1, Isabelle Durand-Joly, Eduardo Dei-Cas

  • 1Laboratoire de parasitologie-mycologie, faculté des sciences pharmaceutiques, université Lille-Nord-de-France, Lille, France.

Medecine Sciences : M/S
|July 19, 2012
PubMed

Insights

Pneumocystis pneumonia is a transmissible fungal disease. Humans are the sole reservoir for Pneumocystis jirovecii, making them the source of infection in both hospital and community settings.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Epidemiology

Context:

  • Pneumocystis pneumonia (PcP) diagnosis and transmission have been historically challenging.
  • Advances in molecular methods and experimental models allow for new investigations into PcP.
  • The Pneumocystis genus, previously thought to be a single species (P. carinii), is now known to comprise multiple species, with P. jirovecii being the human pathogen.

Purpose:

  • To investigate the transmissibility of Pneumocystis pneumonia (PcP).
  • To determine if PcP is a nosocomial or community-acquired infection.
  • To identify the primary reservoir for Pneumocystis jirovecii.

Summary:

  • Pneumocystis exhibits strong host specificity, preventing inter-species transmission.
  • Respiratory transmission is highly efficient between individuals of the same species, including humans.
  • Humans are identified as the exclusive reservoir for P. jirovecii, serving as the sole source of infection.

Impact:

  • This research clarifies the transmission dynamics of PcP.
  • Understanding the human reservoir is crucial for infection control in healthcare and community settings.
  • Findings contribute to the epidemiological understanding of fungal infections.

More Related Videos

Experimental Human Pneumococcal Carriage07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...